{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:25:23Z","timestamp":1790871923416,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Historically, patients with a hematologic malignancy have one of the highest mortality rates among cancer patients admitted to the ICU. Therefore, physicians are often reluctant to admit these patients to the ICU. The aim of our study was to examine the survival of patients who have a hematologic malignancy and multiple organ failure admitted to the ICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>This retrospective cohort study, part of the HEMA-ICU study group, was designed to study the survival of patients with a hematologic malignancy and organ failure after admission to the ICU. Patients were followed for at least 1 year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Five university hospitals in the Netherlands.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>One-thousand ninety-seven patients with a hematologic malignancy who were admitted at the ICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Primary outcome was 1-year survival. Organ failure was categorized as acute kidney injury, respiratory failure, hepatic failure, and hemodynamic failure; multiple organ failure was defined as failure of two or more organs. The World Health Organization performance score measured 3 months after discharge from the ICU was used as a measure of functional outcome. The 1-year survival rate among these patients was 38%. Multiple organ failure was inversely associated with long-term survival, and an absence of respiratory failure was the strongest predictor of 1-year survival. The survival rate among patients with 2, 3, and 4 failing organs was 27%, 22%, and 8%, respectively. Among all surviving patients for which World Health Organization scores were available, 39% had a World Health Organization performance score of 0\u20131 3 months after ICU discharge. Functional outcome was not associated with the number of failing organs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our results suggest that multiple organ failure should not be used as a criterion for excluding a patient with a hematologic malignancy from admission to the ICU.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000003526","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T20:14:40Z","timestamp":1539893680000},"page":"e120-e128","source":"Crossref","is-referenced-by-count":45,"title":["Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care"],"prefix":"10.1097","volume":"47","author":[{"given":"Vera A.","family":"de Vries","sequence":"first","affiliation":[{"name":"Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella C. A.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sesmu","family":"Arbous","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"Biemond","sequence":"additional","affiliation":[{"name":"Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M. A.","family":"Blijlevens","sequence":"additional","affiliation":[{"name":"Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuray","family":"Kusadasi","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Erasmus Medical Center, Rotterdam, The Netherlands."},{"name":"University Medical Center Utrecht, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert R. F.","family":"Span","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P. J.","family":"Vlaar","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"van Westerloo","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"van den Bergh","sequence":"additional","affiliation":[{"name":"Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230815","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","article-title":"Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis.","volume":"360","author":"Brenner","year":"2002","journal-title":"Lancet"},{"key":"R2-20230815","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"R3-20230815","doi-asserted-by":"crossref","first-page":"d1056","DOI":"10.2741\/A831","article-title":"T cells and aging, January 2002 update.","volume":"7","author":"Pawelec","year":"2002","journal-title":"Front Biosci"},{"key":"R4-20230815","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13054-015-1061-z","article-title":"Trends in hospital and intensive care admissions in the Netherlands attributable to the very elderly in an ageing population.","volume":"19","author":"Haas","year":"2015","journal-title":"Crit Care"},{"key":"R5-20230815","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00134-014-3373-x","article-title":"Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units.","volume":"40","author":"van Vliet","year":"2014","journal-title":"Intensive Care Med"},{"key":"R6-20230815","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s00134-008-1003-1","article-title":"Can we still refuse ICU admission of patients with hematological malignancies?","volume":"34","author":"P\u00e8ne","year":"2008","journal-title":"Intensive Care Med"},{"key":"R7-20230815","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc7713","article-title":"Characteristics and outcomes of cancer patients in European ICUs.","volume":"13","author":"Taccone","year":"2009","journal-title":"Crit Care"},{"key":"R8-20230815","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1136\/esmoopen-2015-000018","article-title":"Critically ill patients with cancer: Chances and limitations of intensive care medicine-a narrative review.","volume":"1","author":"Schellongowski","year":"2016","journal-title":"ESMO Open"},{"key":"R9-20230815","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00134-012-2791-x","article-title":"Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: A single center study.","volume":"39","author":"Oeyen","year":"2013","journal-title":"Intensive Care Med"},{"key":"R10-20230815","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01706352","article-title":"Is intensive care justified for patients with haematological malignancies?","volume":"16","author":"Brunet","year":"1990","journal-title":"Intensive Care Med"},{"key":"R11-20230815","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3109\/0284186X.2012.679311","article-title":"Outcomes of cancer patients after unplanned admission to general intensive care units.","volume":"51","author":"Bos","year":"2012","journal-title":"Acta Oncol"},{"key":"R12-20230815","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: Prospective multicenter data from France and Belgium\u2013a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study.","volume":"31","author":"Azoulay","year":"2013","journal-title":"J Clin Oncol"},{"key":"R13-20230815","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1200\/JCO.2005.01.487","article-title":"Outcome of cancer patients considered for intensive care unit admission: A hospital-wide prospective study.","volume":"23","author":"Thi\u00e9ry","year":"2005","journal-title":"J Clin Oncol"},{"key":"R14-20230815","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00277-013-1675-7","article-title":"Outcome of critically ill patients with hematological malignancies.","volume":"92","author":"Namendys-Silva","year":"2013","journal-title":"Ann Hematol"},{"key":"R15-20230815","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/bja\/aer449","article-title":"Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: A 5 yr study.","volume":"108","author":"Bird","year":"2012","journal-title":"Br J Anaesth"},{"key":"R16-20230815","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00003246-200301000-00017","article-title":"Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication.","volume":"31","author":"Benoit","year":"2003","journal-title":"Crit Care Med"},{"key":"R17-20230815","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/annonc\/mdq711","article-title":"Impact of neutropenia on the outcomes of critically ill patients with cancer: A matched case-control study.","volume":"22","author":"Souza-Dantas","year":"2011","journal-title":"Ann Oncol"},{"key":"R18-20230815","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1186\/s40064-016-3714-z","article-title":"The prognostic factors for patients with hematological malignancies admitted to the intensive care unit.","volume":"5","author":"Cheng","year":"2016","journal-title":"Springerplus"},{"key":"R19-20230815","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/ndt\/gfv372","article-title":"Acute kidney injury in critically ill patients with haematological malignancies: Results of a multicentre cohort study from the Groupe de Recherche en R\u00e9animation Respiratoire en Onco-H\u00e9matologie.","volume":"30","author":"Darmon","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R20-20230815","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1179\/1607845414Y.0000000206","article-title":"Hematologic malignancies in the medical intensive care unit\u2013Outcomes and prognostic factors.","volume":"20","author":"Grgi\u0107 Medi\u0107","year":"2015","journal-title":"Hematology"},{"key":"R21-20230815","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/bmt.2015.269","article-title":"A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: Results of a 5-year cohort study (2009-2013).","volume":"51","author":"Platon","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"R22-20230815","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s00134-006-0286-3","article-title":"Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU.","volume":"32","author":"Lamia","year":"2006","journal-title":"Intensive Care Med"},{"key":"R23-20230815","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1034\/j.1399-6576.2003.00058.x","article-title":"Multiple organ failure and outcome of critically ill patients with haematological malignancy.","volume":"47","author":"Silfvast","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"R24-20230815","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/cc8016","article-title":"Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: A secondary analysis of the ICNARC Case Mix Programme Database.","volume":"13","author":"Hampshire","year":"2009","journal-title":"Crit Care"},{"key":"R25-20230815","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: A severity of disease classification system.","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"R26-20230815","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/ije\/dyv291","article-title":"Data resource profile: The Dutch National Intensive Care Evaluation (NICE) registry of admissions to adult intensive care units.","volume":"44","author":"van de Klundert","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R29-20230815","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-008-1002-2","article-title":"Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.","volume":"34","author":"Vandijck","year":"2008","journal-title":"Intensive Care Med"},{"key":"R30-20230815","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.md.0000145370.63676.fb","article-title":"The prognosis of acute respiratory failure in critically ill cancer patients.","volume":"83","author":"Azoulay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R31-20230815","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.121.1.185","article-title":"Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation.","volume":"121","author":"Khassawneh","year":"2002","journal-title":"Chest"},{"key":"R32-20230815","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3414\/ME12-02-0070","article-title":"Reliability of in-hospital mortality as a quality indicator in clinical quality registries. A case study in an intensive care quality register.","volume":"52","author":"Koetsier","year":"2013","journal-title":"Methods Inf Med"},{"key":"R33-20230815","first-page":"268","article-title":"Characteristics and outcomes of patients with a haematological malignancy admitted to the intensive care unit for a neurological event.","volume":"17","author":"Riedijk","year":"2015","journal-title":"Crit Care Resusc"},{"key":"R34-20230815","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3109\/10428194.2016.1163345","article-title":"Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancy.","volume":"57","author":"Hamaker","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"R35-20230815","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00277-010-0956-7","article-title":"Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma.","volume":"89","author":"Hirakawa","year":"2010","journal-title":"Ann Hematol"},{"key":"R36-20230815","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1097\/00003246-200210000-00014","article-title":"Prognosis of hematologic malignancies does not predict intensive care unit mortality.","volume":"30","author":"Massion","year":"2002","journal-title":"Crit Care Med"},{"key":"R37-20230815","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccc.2015.06.004","article-title":"Thrombocytopenia-associated multiple organ failure and acute kidney injury.","volume":"31","author":"Nguyen","year":"2015","journal-title":"Crit Care Clin"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201902000-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:03:21Z","timestamp":1692144201000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201902000-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000003526","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}